1. Home
  2. NEPH vs GRF Comparison

NEPH vs GRF Comparison

Compare NEPH & GRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • GRF
  • Stock Information
  • Founded
  • NEPH 1997
  • GRF 1989
  • Country
  • NEPH United States
  • GRF United States
  • Employees
  • NEPH N/A
  • GRF N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • GRF Finance/Investors Services
  • Sector
  • NEPH Health Care
  • GRF Finance
  • Exchange
  • NEPH Nasdaq
  • GRF Nasdaq
  • Market Cap
  • NEPH 37.4M
  • GRF 39.3M
  • IPO Year
  • NEPH 2004
  • GRF N/A
  • Fundamental
  • Price
  • NEPH $4.13
  • GRF $10.11
  • Analyst Decision
  • NEPH Strong Buy
  • GRF
  • Analyst Count
  • NEPH 2
  • GRF 0
  • Target Price
  • NEPH $5.50
  • GRF N/A
  • AVG Volume (30 Days)
  • NEPH 48.3K
  • GRF 3.0K
  • Earning Date
  • NEPH 08-07-2025
  • GRF 01-01-0001
  • Dividend Yield
  • NEPH N/A
  • GRF 3.70%
  • EPS Growth
  • NEPH N/A
  • GRF N/A
  • EPS
  • NEPH 0.12
  • GRF 1.16
  • Revenue
  • NEPH $16,684,000.00
  • GRF N/A
  • Revenue This Year
  • NEPH $17.06
  • GRF N/A
  • Revenue Next Year
  • NEPH $12.20
  • GRF N/A
  • P/E Ratio
  • NEPH $34.23
  • GRF $8.15
  • Revenue Growth
  • NEPH 21.16
  • GRF N/A
  • 52 Week Low
  • NEPH $1.36
  • GRF $7.93
  • 52 Week High
  • NEPH $5.00
  • GRF $10.19
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 56.97
  • GRF 49.92
  • Support Level
  • NEPH $3.75
  • GRF $10.02
  • Resistance Level
  • NEPH $4.59
  • GRF $10.15
  • Average True Range (ATR)
  • NEPH 0.45
  • GRF 0.06
  • MACD
  • NEPH 0.08
  • GRF -0.02
  • Stochastic Oscillator
  • NEPH 60.19
  • GRF 25.53

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About GRF Eagle Capital Growth Fund Inc.

Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.

Share on Social Networks: